机构：[1]Department of Urology, Institute of Urology, Sichuan University, Chengdu, 610041, PR China[2]West China School of Medicine, West China Hospital, Sichuan University, Chengdu, 610041, PR China四川大学华西医院[3]Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, PR China
This program was supported by the Luzhou City Science and
Technology Bureau (grant number 2021LZXNYDJ10 and
2020LZXNYDJ14), Cooperation Project between the Second People's
Hospital of Deyang and Southwest Medical University
(2022DYEXNYD002).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|3 区医学
小类|3 区外科
最新[2023]版：
大类|3 区医学
小类|3 区外科
第一作者：
第一作者机构：[1]Department of Urology, Institute of Urology, Sichuan University, Chengdu, 610041, PR China[2]West China School of Medicine, West China Hospital, Sichuan University, Chengdu, 610041, PR China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Urology, Institute of Urology, Sichuan University, Chengdu, 610041, PR China[2]West China School of Medicine, West China Hospital, Sichuan University, Chengdu, 610041, PR China
推荐引用方式(GB/T 7714)：
Xiao Yuhan,Wang Jie,Feng Dechao,et al.TEX19 could function as a prognostic biomarker for prostate cancer patients[J].Asian journal of surgery.2023,doi:10.1016/j.asjsur.2023.08.076.
APA：
Xiao Yuhan,Wang Jie,Feng Dechao&Zhang Chi.(2023).TEX19 could function as a prognostic biomarker for prostate cancer patients.Asian journal of surgery,,
MLA：
Xiao Yuhan,et al."TEX19 could function as a prognostic biomarker for prostate cancer patients".Asian journal of surgery .(2023)
